Strata Critical Medical Inc [SRTA] stock is trading at $5.87, up 2.80%. An important factor to consider is whether the stock is rising or falling in short-term value. The SRTA shares have gain 29.58% over the last week, with a monthly amount glided 38.44%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Strata Critical Medical Inc [NASDAQ: SRTA] stock has seen the most recent analyst activity on February 26, 2025, when Lake Street initiated its Buy rating and assigned the stock a price target of $6.50. Previously, Ladenburg Thalmann started tracking the stock with Buy rating on July 18, 2023, and set its price target to $13. On July 17, 2023, Ladenburg Thalmann initiated with a Buy rating and assigned a price target of $13 on the stock. Oppenheimer started tracking the stock assigning a Outperform rating and suggested a price target of $14 on September 28, 2021. JP Morgan initiated its recommendation with a Overweight and recommended $16 as its price target on September 09, 2021. Deutsche Bank started tracking with a Buy rating for this stock on September 01, 2021, and assigned it a price target of $15. In a note dated August 26, 2021, Credit Suisse initiated an Outperform rating and provided a target price of $14 on this stock.
Strata Critical Medical Inc [SRTA] stock has fluctuated between $2.35 and $6.02 over the past year. Currently, Wall Street analysts expect the stock to reach $7.25 within the next 12 months. Strata Critical Medical Inc [NASDAQ: SRTA] shares were valued at $5.87 at the most recent close of the market. An investor can expect a potential return of 23.51% based on the average SRTA price forecast.
Analyzing the SRTA fundamentals
Strata Critical Medical Inc [NASDAQ:SRTA] reported sales of 254.34M for the trailing twelve months, which represents a growth of 4.20%. Gross Profit Margin for this corporation currently stands at 0.24% with Operating Profit Margin at -0.1%, Pretax Profit Margin comes in at -0.08%, and Net Profit Margin reading is -0.07%. To continue investigating profitability, this company’s Return on Assets is posted at -0.07, Equity is -0.08 and Total Capital is -0.11. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.56 points at the first support level, and at 5.26 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.04, and for the 2nd resistance point, it is at 6.22.
Ratios To Look Out For
For context, Strata Critical Medical Inc’s Current Ratio is 5.95. On the other hand, the Quick Ratio is 5.95, and the Cash Ratio is 2.23. Considering the valuation of this stock, the price to sales ratio is 1.89, the price to book ratio is 2.15.
Transactions by insiders
Recent insider trading involved Tomkiel Melissa M., President and General Counsel, that happened on Aug 04 ’25 when 47995.0 shares were sold. Chief Financial Officer, Heyburn William A. completed a deal on Aug 04 ’25 to sell 46918.0 shares. Meanwhile, Officer MELISSA TOMKIEL bought 47995.0 shares on Aug 04 ’25.